ASPREE-D; Aspirin in the prevention of depression in the elderly [ 2015 - 2018 ]

Research Grant

Researchers: Prof Michael Berk (Principal investigator) ,  A/Pr Robyn Woods ,  Dr Mohammadreza Mohebbi ,  Prof John Mcneil ,  Prof Mark Nelson

Brief description The ASPREE (ASPirin in Reducing Events in the Elderly) study is a 5 year RCT of aspirin (100mg daily) or placebo in 19,000 healthy people over 70. We aim to augment the existing infrastructure of ASPREE in order to confirm the utility of aspirin for the prevention of depression in the elderly (ASPREE-D). The primary aim of ASPREE-D is to determine if use of low-dose aspirin reduces the incidence of de-novo episodes of depression in healthy individuals over 70 years of age.

Funding Amount $AUD 796,784.88

Funding Scheme Project Grants

Notes Standard Project Grant